Medicare Bill Retains ANDA “Antibundling” Language “Livable” To GPhA

Medicare prescription drug benefit legislation is likely to contain a modified version of the House bill's "antibundling" provision for generic drug applications following a Sept. 30 Capitol Hill meeting between the brand and generic drug industries